2016
DOI: 10.1016/j.stemcr.2016.09.013
|View full text |Cite
|
Sign up to set email alerts
|

Small Molecules Modulate Chromatin Accessibility to Promote NEUROG2-Mediated Fibroblast-to-Neuron Reprogramming

Abstract: SummaryPro-neural transcription factors and small molecules can induce the reprogramming of fibroblasts into functional neurons; however, the immediate-early molecular events that catalyze this conversion have not been well defined. We previously demonstrated that neurogenin 2 (NEUROG2), forskolin (F), and dorsomorphin (D) can reprogram fibroblasts into functional neurons with high efficiency. Here, we used this model to define the genetic and epigenetic events that initiate an acquisition of neuronal identity… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

3
111
0
1

Year Published

2018
2018
2022
2022

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 102 publications
(115 citation statements)
references
References 49 publications
(71 reference statements)
3
111
0
1
Order By: Relevance
“…Interestingly, while TGF/ALK/SMAD and GSK3b inhibition is thought to destabilize non-neuronal identities and promote neuronal fate-stabilizing signaling [61], forskolin was shown to directly prime chromatin accessibility for more efficient Ngn2-only conversion, a pioneer-enhancing activity previously ascribed exclusively to TFs (Fig. 1D) [33]. Subsequently, it has been shown that additional pathway modulations, including SIRT1 activation and HDAC inhibition, can be applied to increase the efficacy and maturity of the neuronal population obtained [62].…”
Section: Nongenetic In Boostersmentioning
confidence: 78%
See 2 more Smart Citations
“…Interestingly, while TGF/ALK/SMAD and GSK3b inhibition is thought to destabilize non-neuronal identities and promote neuronal fate-stabilizing signaling [61], forskolin was shown to directly prime chromatin accessibility for more efficient Ngn2-only conversion, a pioneer-enhancing activity previously ascribed exclusively to TFs (Fig. 1D) [33]. Subsequently, it has been shown that additional pathway modulations, including SIRT1 activation and HDAC inhibition, can be applied to increase the efficacy and maturity of the neuronal population obtained [62].…”
Section: Nongenetic In Boostersmentioning
confidence: 78%
“…Chromatin accessibility and transcriptome data have suggested that Zfp238, Sox8, and Dlx3 are among the most important endogenous secondary TF genes downstream of Ascl1 [32]. Some data indicate that Ngn2, when using an appropriate conversion medium, not only binds most of the Ascl1 binding sites in fibroblasts, but also possesses many additional binding sites [30,33]. However, other data suggest that Ascl1 and Ngn2 possess divergent binding patterns that result in distinct chromatin states and different neuronal fates [34].…”
Section: Enabling In Conversionmentioning
confidence: 99%
See 1 more Smart Citation
“…Ascl1 belongs to the family of the basic helix-loop-helix family, and it specifically binds DNA sequences containing an E-box motif [10]. Also, microRNAs [13][14][15][16] and small molecules [17][18][19][20] have been shown to play a critical role in the conversion process. Many other TFs can also contribute to the reprogramming, such as brain-specific homeobox/POU domain protein 2 (Brn2) that does not access fibroblast chromatin actively on their own but it is recruited by Ascl1 [11,12].…”
mentioning
confidence: 99%
“…Many other TFs can also contribute to the reprogramming, such as brain-specific homeobox/POU domain protein 2 (Brn2) that does not access fibroblast chromatin actively on their own but it is recruited by Ascl1 [11,12]. Also, microRNAs [13][14][15][16] and small molecules [17][18][19][20] have been shown to play a critical role in the conversion process. Overexpression of neuron-specific microRNA miR124 triggers a neuronal gene expression profile in a number of different cell types: HeLa cells, human embryonic carcinoma stem cells (NT2), mouse neuronal progenitor cells (N2A), human retinal epithelial cells (ARPE19), and primary mouse embryonic fibroblasts [21].…”
mentioning
confidence: 99%